Use of Patient Preferences Data Regarding Multiple Risks to Inform Regulatory Decisions

by J. Felipe Montano-Campos, Juan Marcos Gonzalez, Timothy Rickert, Angelyn O. Fairchild, Bennett Levitan, Shelby D. Reed
Published 2023-01-01

Japanese Patients’ and Physicians’ Preferences for Anticoagulant Use in Atrial Fibrillation: Results from a Discrete-choice Experiment

by Ken Okumura, Hiroshi Inoue, Masahiro Yasaka, Juan Marcos Gonzalez, A. Brett Hauber, Bennett Levitan, Zhong Yuan, Jean Baptiste Briere

Appraising patient preference methods for decision-making in the medical product lifecycle: an empirical comparison

by Chiara Whichello, Bennett Levitan, Juhaeri Juhaeri, Vaishali Patadia, Rachael DiSantostefano, Cathy Anne Pinto, Esther W. de Bekker-Grob
Published 2020-06-01

Benefit–Risk of Rivaroxaban for Extended Thromboprophylaxis After Hospitalization for Medical Illness: Pooled Analysis From MAGELLAN and MARINER

by Gary E. Raskob, Alex C. Spyropoulos, Theodore E. Spiro, Wentao Lu, Zhong Yuan, Bennett Levitan, Eunyoung Suh, Elliot S. Barnathan
Published 2021-11-01

Quantitative Benefit–Risk Evaluation of Rivaroxaban in Patients After Peripheral Arterial Revascularization: The VOYAGER PAD Trial

by Zhong Yuan, Bennett Levitan, Hsiaowei Deng, Michael Szarek, Rupert M. Bauersachs, Scott D. Berkowitz, Lloyd Haskell, Elliot S. Barnathan, Marc P. Bonaca
Published 2024-04-01

Opportunities and challenges for the inclusion of patient preferences in the medical product life cycle: a systematic review

by Rosanne Janssens, Isabelle Huys, Eline van Overbeeke, Chiara Whichello, Sarah Harding, Jürgen Kübler, Juhaeri Juhaeri, Antonio Ciaglia, Steven Simoens, Hilde Stevens, Meredith Smith, Bennett Levitan, Irina Cleemput, Esther de Bekker-Grob, Jorien Veldwijk
Published 2019-10-01

Benefit–Risk Assessment of Rivaroxaban for Extended Thromboprophylaxis After Hospitalization for Medical Illness

by Gary E. Raskob, Walter Ageno, Gregory Albers, C. Gregory Elliott, Jonathan Halperin, Gregory Maynard, Philippe Gabriel Steg, Jeffrey I. Weitz, John Albanese, Zhong Yuan, Bennett Levitan, Wentao Lu, Eun Young Suh, Theodore Spiro, Concetta Lipardi, Elliot S. Barnathan, Alex C. Spyropoulos
Published 2022-10-01

How can patient preferences be used and communicated in the regulatory evaluation of medicinal products? Findings and recommendations from IMI PREFER and call to action

by Rosanne Janssens, Liese Barbier, Mireille Muller, Irina Cleemput, Isabelle Stoeckert, Chiara Whichello, Bennett Levitan, Tarek A. Hammad, Charis Girvalaki, Juan-Jose Ventura, Karin Schölin Bywall, Karin Schölin Bywall, Cathy Anne Pinto, Elise Schoefs, Eva G. Katz, Ulrik Kihlbom, Isabelle Huys
Published 2023-08-01

A study protocol for quantifying patient preferences in neuromuscular disorders: a case study of the IMI PREFER Project [version 1; peer review: 2 approved]

by Aura Cecilia Jimenez-Moreno, Cathy Anne Pinto, Bennett Levitan, Chiara Whichello, Christine Dyer, Eline Van Overbeeke, Esther de Bekker-Grob, Ian Smith, Isabelle Huys, Jennifer Viberg Johansson, Kate Adcock, Kristin Bullock, Vikas Soekhai, Zhong Yuan, Hanns Lochmuller, Ardine de Wit, Grainne S. Gorman
Published 2020-10-01

Factors and Situations Affecting the Value of Patient Preference Studies: Semi-Structured Interviews in Europe and the US

by Chiara Whichello, Eline van Overbeeke, Rosanne Janssens, Karin Schölin Bywall, Selena Russo, Jorien Veldwijk, Irina Cleemput, Juhaeri Juhaeri, Bennett Levitan, Jürgen Kübler, Meredith Smith, Richard Hermann, Matthias Englbrecht, Axel J. Hueber, Alina Comanescu, Sarah Harding, Steven Simoens, Isabelle Huys, Esther W. de Bekker-Grob
Published 2019-09-01

Design, Conduct, and Use of Patient Preference Studies in the Medical Product Life Cycle: A Multi-Method Study

by Eline van Overbeeke, Rosanne Janssens, Chiara Whichello, Karin Schölin Bywall, Jenny Sharpe, Nikoletta Nikolenko, Berkeley S. Phillips, Paolo Guiddi, Gabriella Pravettoni, Gabriella Pravettoni, Laura Vergani, Laura Vergani, Giulia Marton, Giulia Marton, Irina Cleemput, Steven Simoens, Jürgen Kübler, Juhaeri Juhaeri, Bennett Levitan, Esther W. de Bekker-Grob, Jorien Veldwijk, Isabelle Huys
Published 2019-12-01

Improved Benefit Risk Profile of Rivaroxaban in a Subpopulation of the MAGELLAN Study

by Alex C. Spyropoulos MD, Concetta Lipardi MD, PhD, Jianfeng Xu PhD, Wentao Lu PhD, Eunyoung Suh PhD, Zhong Yuan MD, PhD, Bennett Levitan MD, PhD, Chiara Sugarmann BSN, MSHS, Yoriko De Sanctis MS, Theodore E. Spiro MD, Elliot S. Barnathan MD, Gary E. Raskob PhD
Published 2019-11-01